Valued at USD 3.63 billion in 2021, the Anastomosis Devices Market is projected to reach USD 5.89 billion by 2030, growing at a CAGR of 5.7% during the forecast period 2022–2030, according to Polaris Market Research. The report uses 2021 as its base year and draws on historical data from 2018 to 2020. Leading participants include Aesdex, B. Braun, Ethicon, Getinge, LivaNova PLC, MAQUET Holding, Medtronic, Novare Surgical Systems, Peters Surgical, and Vitalitec International. For device manufacturers, hospital procurement teams, and healthcare investors, this outlook describes a procedure-driven category in which clinical demand, surgical technique, and product engineering advance together.

Polaris attributes growth to the rising number of cardiac and gastrointestinal procedures performed worldwide. A growing geriatric population and increasing healthcare expenditure by governments in several countries add further momentum. Together, these factors tie demand to the volume of surgical procedures. Polaris identifies the rising prevalence of cardiovascular and gastrointestinal diseases as the primary driver of industry growth, and notes that the growing incidence of target diseases contributes significantly to global expansion.

Disease Burden Lifting Demand for Cardiovascular Surgeries

The disease burden is the clearest demand signal. According to WHO survey reports cited in the Polaris analysis, 17.9 million people died from cardiovascular diseases in 2019, and COVID-19 has since increased the number of cardiovascular cases worldwide. Within the application segmentation, cardiovascular surgeries are projected to record the highest growth rate over the study period, driven by the rising prevalence of cardiovascular disease and by surgeons' wider use of highly non-invasive techniques. Unhealthy food habits and sedentary lifestyles are also cited as catalysts that expand the patient pool.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/anastomosis-devices-market

Minimally Invasive Surgeries and Device Innovation

Rising demand for high-quality minimally invasive surgeries is positively influencing industry growth and pushing manufacturers toward more precise solutions. One example is the development of a sutureless anastomosis device by Jomed International of Helsingborg, Sweden, intended to perform quick sutureless vascular anastomosis. Becton, CONMED Corporation, and Meril Life Sciences are also investing heavily in research and development to deliver advanced anastomosis equipment with better clinical results. Beyond cardiac and gastrointestinal care, growing requirements in orthopedic, gynecological, and ophthalmic procedures are creating a positive outlook for the Anastomosis Devices Market.

Type Segmentation Across the Anastomosis Devices Market

The report segments the market by type, application, end-use, and region. Within type, the portfolio spans surgical staplers, available in manual and powered formats; surgical sutures, including absorbable options (synthetic and natural) and non-absorbable options; and surgical sealants and adhesives, divided into natural/biological and synthetic and semisynthetic categories. A further category covers automated devices. This breadth gives suppliers several entry points into the category and gives buyers several ways to approach tissue joining. The regional scope spans North America (the U.S. and Canada), Europe, Asia Pacific, Latin America, and the Middle East and Africa, with country-level coverage that includes Japan, China, India, Malaysia, Indonesia, and South Korea in Asia Pacific.

Regional Signals and Operating Headwinds

North America is the greatest revenue contributor, supported by the region's prevalence of cardiovascular disease, rising government healthcare expenditure, a growing number of cancer patients, and active research and development by market players. Asia Pacific is expected to rise substantially during the forecast period, aided by healthcare infrastructure development, inflating disposable incomes, and a growing geriatric population.

Headwinds remain. The COVID-19 pandemic reduced demand for anastomosis equipment because a shortage of devices created a gap between demand and supply for complex surgeries, although Polaris expects improving conditions to restore demand. The report's table of contents also identifies the high cost of devices as a restraint and rates rivalry among existing firms as high.

Strategic Takeaways for B2B Stakeholders

For manufacturers, distributors, and healthcare providers, the Anastomosis Devices Market offers a procedure-linked growth path through 2030. The Polaris data points to research investment, alignment with cardiovascular and minimally invasive demand, and close attention to Asia Pacific expansion as the clearest priorities. North America is the current revenue leader, while Asia Pacific is the region to watch.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market